Comparative guide · 5 min read

Apigenin vs Glycine for sleep — which one for which sleep problem?

Updated 2026-05-18 · Reviewed by SupplementScore editors · No sponsorships

Both ride the long tail of the "natural sleep aid" supplement market — but their mechanisms and evidence levels are very different. Apigenin is a flavonoid found at high concentration in chamomile and parsley, with mostly preclinical GABAergic data and a small chamomile-extract clinical literature. Glycine is a non-essential amino acid with a small but cleaner human trial base showing improvements in subjective sleep quality, sleep onset latency, and core-temperature drop. Neither is a sledgehammer; both fit specific sleep complaints.

Quick verdict

Sleep complaintBetter choiceWhy
Difficulty falling asleep (long sleep-onset latency)GlycineMultiple small RCTs show reduced sleep-onset latency.
Anxious-mind "wired but tired" with racing thoughtsApigenin (or chamomile extract)GABAergic anxiolytic profile in trials of generalised anxiety.
Sleep quality / next-day fatigue without onset problemsGlycineTrial signal on next-day refreshment and reduced daytime fatigue.
Stress-pattern sleep with cortisol-driven 3am wakingsApigenin (limited evidence)Mechanism suggests CRH/HPA modulation; clinical data thin.
Hot sleepers / core-temperature regulation issuesGlycineDocumented effect on lowering core body temperature.
Sleep with comorbid mild generalised anxietyApigenin (or chamomile)Chamomile-extract trial in GAD showed sleep co-benefit.
Shift workers needing daytime sleepGlycine + light hygieneLower-cost, well-tolerated; pair with blackout / melatonin if needed.
Older adults with light, fragmented sleepGlycine (with caution on polypharmacy)Better-tolerated, fewer drug interactions.

How they compare on the things that matter

Mechanism — flavonoid GABA modulator vs inhibitory amino acid

Apigenin is a flavone with documented in vitro binding at GABA-A benzodiazepine receptors (the same site benzodiazepines act on, but at much lower potency). Chamomile (Matricaria recutita) is the most concentrated dietary source. Most of the clinical data on apigenin comes from standardised chamomile-extract trials rather than isolated apigenin trials, because apigenin in capsule form is a relatively recent supplement category.

Glycine is a non-essential amino acid that acts as an inhibitory neurotransmitter at glycine receptors in the brainstem and spinal cord, and as a co-agonist at NMDA receptors. The most-cited sleep mechanism is peripheral: glycine appears to promote cutaneous vasodilation and increase distal-extremity heat loss, which lowers core body temperature — a physiological prerequisite for sleep onset.

Evidence base by endpoint

Practical rule. If the dominant problem is "can't fall asleep / takes me 45+ minutes to drop off" or "wakes up tired despite full night in bed," glycine 3 g at bedtime is the cleaner first trial. If the dominant problem is "anxious mind, racing thoughts that prevent sleep onset" or paired with daytime generalised anxiety, standardised chamomile extract (or apigenin 50 mg) is a reasonable trial. Both are mild — neither replaces sleep hygiene fixes (consistent wake time, dark room, screen-reduction, no late caffeine).

Dose and form

For glycine, 3 g (one rounded teaspoon of the powder) taken 30–60 minutes before bed. The taste is mildly sweet; mixes well in water. Higher doses are well-tolerated but the trial dose is 3 g. Some users prefer capsules (typically 6–8 × 500 mg).

For apigenin, 50 mg of an isolated apigenin supplement is the typical "biohacker" dose, taken 30–60 minutes before bed. An alternative is standardised chamomile extract (Matricaria 220 mg standardised to 1.2% apigenin) — the form used in the clinical trial literature for generalised anxiety.

Safety

Glycine is well-tolerated at supplement doses. The main caution: avoid in clozapine therapy (glycine has been studied as adjunct in schizophrenia and may interact). No clinically significant interactions in the general population.

Apigenin is generally well-tolerated. Theoretical interactions include CYP3A4 inhibition at higher doses (potentially raising levels of statins, calcium-channel blockers, and other 3A4-metabolised drugs), and mild anticoagulant effect (relevant for users on warfarin or DOACs). Chamomile allergy (in users with ragweed/Asteraceae allergies) can produce reactions. Pregnancy data are inadequate; avoid.

What the price difference buys you

Glycine powder runs $0.05–0.15/day at the 3 g dose — among the cheapest functional supplements per use. Apigenin isolate (50 mg) runs $0.30–0.80/day; standardised chamomile extract runs $0.20–0.50/day. Both are inexpensive.

Who should skip each

Glycine should be avoided in clozapine therapy. No other clear contraindications at supplement doses.

Apigenin should be avoided in: pregnancy and breastfeeding, users on warfarin or DOACs, users with Asteraceae-family allergy (ragweed, marigold), and users on multiple CYP3A4-metabolised medications.

What we'd actually buy

For most users with sleep-onset difficulty: glycine 3 g taken 30–60 minutes before bed, paired with the standard sleep-hygiene work (consistent wake time, cool bedroom, screen-reduction past sunset, no late caffeine). Run 2–4 weeks; if no improvement, glycine is not the rate-limiting input.

For users with prominent anxious-mind sleep onset and mild generalised anxiety: standardised chamomile extract 220 mg (1.2% apigenin) 30–60 minutes before bed, with the same sleep-hygiene work.

For users with both — glycine 3 g + chamomile 220 mg can stack at minimal cost. Layer either on top of magnesium glycinate 200–400 mg elemental if magnesium status is likely low.

Sources

Read more: